Celia Morgan

https://psychology.exeter.ac.uk/staff/profile/index.php?web_id=Celia_Morgan

Awakn Life Sciences’ Phase III Trial to Be Delivered in the UK National Health Service

Awakn Life Sciences Corp. (NEO: AWKN | OTCQB: AWKNF | FSE: 954), a revenue-generating biotechnology company researching, developing, and commercializing therapeutics to treat addiction with...

Awakn Makes Its Case To Investors

British psychiatrist Ben Sessa believes fervently in psychedelic medicines. They are “likely to change the whole paradigm of psychiatry,” says Sessa, the chief medical officer...

A Deeper Look at Ketamine for Alcohol Use Disorder | Microdose

Ketamine psychedelic therapy. The mechanism behind the effectiveness of psychedelics for the treatment of substance misuse is based on reduction in ...

Psychedelic Series London

Jul 06, 2022

Ketamine use: a review

CJA Morgan, HV Curran… - …, 2012 - Wiley Online Library

Acute and chronic effects of ketamine upon human memory: a review

CJA Morgan, HV Curran - Psychopharmacology, 2006 - Springer

researchgate.net

Last updated: Aug 18, 2020

Request Deletion